Start
«
1
2
3
»
End
Page 2 of 3
Results 76 - 150 of 206
15
30
60
75
150
A New Paradigm in Treating ILD
A Collaborative Approach to IPF Management
Practical Solutions to SSc-ILD Treatment
Post COVID-19 and Patients With and Without Pre-existing ILD
How to Choose the Right Therapy for Your Patients with IPF
PAH: Aligning Treatment Strategy to Risk Level
PAH: Identifying Side Effects and Optimizing Therapy to Improve Patient Outcomes
Patient Develops de novo Features of ILD After a COVID Infection
SSc-ILD Individualized Treatment
Overlapping Symptoms and Risk Factors for COVID and IPF
Multidisciplinary Management of IPF
Fundamentals of Diagnosis: SSc-ILD
Fundamentals of Diagnosis: PF-ILD
Beyond The Basics Of PAH
IPF Management in Practice: A Truly Interactive Experience
COVID-19 Associated ARDS
COVID-19 and Comorbid ILD
Three Cases of Lung Fibrosis in Patients With COVID-19
Assessing a Patient With Long COVID-19
COVID-19 Acute and Long-term Lung Injury
COVID-19: An Animated Video Series
COVID-19 and ARDS: East Coast Experiences
IPF Animated Video Series: Micro-learning focusing on the soft skills
Practical Applications From What We Heard at Virtual ACR
Learning From SARS and MERS: What Should We Expect for COVID-19 Patients
COVID-19 and Lung Injury/Fibrosis
End of Life in IPF
Comprehensive Care of the ILD Patient–Focus on Symptoms
Developing an Action Plan to Manage IPF
Diagnosis of Interstitial Lung Disease
Allergic Asthma: Virtual Conference Coverage
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
New Directions in the Diagnosis of RA ILD
Therapies on the Horizon for RA ILD
New Treatment Options for SSc ILD
Updates on Current Treatment Options for RA ILD
Learnings From the Virtual ERS International Congress
Practical Questions in the Diagnosis and Management of Patients With MAC
COVID-19 and ARDS: West Coast Experiences
Biochemical Profiles of Radiographic Patterns in SSc-ILD
Factors Associated with Disease Progression in the SENSCIS Trial
Machine Learning Assisted Prediction of Progression in SSc-ILD
What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD
Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
Updates on Current Treatment Options for RA-ILD
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
Utilizing ACIP's Updated Pneumococcal Recommendations - Rapid Recap
PILOTforPulmonary 2019: Data, Insights & Practice
Managing the Whole Patient with COPD: An Animated Video Series
My COPD Action Plan
Expert Recommendations for COPD
How Can Targeting the Endocannabinoid System Help to Resolve CF Inflammation
Previous Approaches that Tried to Target Inflammation in Cystic Fibrosis
Inflammation in Cystic Fibrosis
Understanding the Endocannabinoid System (Cystic Fibrosis)
Surgical and Minimally Invasive Procedures that Might Benefit COPD Patients
COPD: Fixed Dose Combinations
COPD: Proper Inhaler Use
Clinical Pearls from New Orleans 2019
Inhaled NO in Patients at Risk for Pulmonary Hypertension
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
Considerations for Geriatric ILD Patients
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
Emerging Diagnostic Approaches to Patients with ILD
Goals of Care Across the Disease Continuum in IPF
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Current Perspective on Antifibrotic Therapy for Patients with IPF
Pulmonologists as the Gatekeepers of Precision Medicine
Interstitial Pneumonia with Autoimmune Features (IPAF)
How to Identify & Manage Patients with Progressive-Fibrosing ILD
Acute Exacerbations of IPF
Personalized Medicine for Improving Asthma Care: An Animated Video Series
New Developments in Pulmonary Diseases: Optimizing Patient Outcomes
Start
«
1
2
3
»
End
Page 2 of 3
